Integrative transcriptomic and immune-genomic analysis identifies oxidative-stress-associated immune signatures and SPTLC1, PTGES3, and HLA-G as candidate hub genes in chronic insomnia
Aug 2026· Egyptian Journal of Medical Human Genetics· Vol 27· 0 citations· 49 references
TL;DR
An integrative transcriptomic and immune-genomic characterization of chronic insomnia is provided and SPTLC1, PTGES3, and HLA-G are identified as candidate hub genes associated with oxidative-stress-related immune signatures.
Abstract
Chronic insomnia involves peripheral immune dysregulation, yet its dominant perturbation pathways, candidate immune-genomic markers, and the relative contributions of germline genetic versus non-genetic regulation remain unclear. We analyzed the GSE208668 peripheral blood mononuclear cell microarray dataset comprising 17 patients with chronic insomnia and 25 controls through an integrative transcriptomic and immune-genomic pipeline. Oxidative-stress- and immune-related pathway alterations were characterized using pathway scoring, differential expression analysis, weighted gene co-expression network analysis, machine-learning-based feature prioritization, immune-cell deconvolution, cross-cohort transcriptomic comparison, SMR/HEIDI analysis, and drug–gene interaction screening. The insomnia-associated co-expression module was enriched for immune regulation, inflammatory signaling, antigen presentation, and stress-response processes. Machine-learning prioritization highlighted a set of candidate genes, among which SPTLC1, PTGES3, and HLA-G emerged as core consensus hub genes. Within the discovery dataset, these genes showed strong separation between insomnia and control samples. Internal classification analysis based on the three-gene model showed complete separation in the discovery cohort; however, this finding should be interpreted as internal separability rather than clinical diagnostic validity. SMR/HEIDI analysis did not identify Bonferroni-significant cis-eQTL-mediated germline regulatory evidence for the testable candidate genes, suggesting that the observed transcriptional alterations were not readily explained by detectable germline regulatory effects under the current data and analysis framework. Drug–gene interaction screening further identified potentially actionable gene–drug links for hypothesis generation. This study provides an integrative transcriptomic and immune-genomic characterization of chronic insomnia and identifies SPTLC1, PTGES3, and HLA-G as candidate hub genes associated with oxidative-stress-related immune signatures. These findings are exploratory and require confirmation in larger independent cohorts and experimental studies before clinical translation.
This study suggests that CDC20 may serve as a potential biomarker for cell cycle and immune-inflammatory processes in psoriasis, providing a basis for further mechanistic and translational studies.
Ling-Yi Yang, Wen-Sheng Mo, Gang Wang et al.· Clinical, Cosmetic and Inves...· 0 citations
A potentially previously unrecognized association among lipopolysaccharide-related genes, iron metabolism imbalance, and immune dysregulation in polycystic ovary syndrome is suggested, thereby providing a potential framework for future mechanistic investigations and the development of diagnostic and therapeutic targets...
Yang Li, Chunmei Bai, Xumin Zhang et al.· Scientific Reports· 0 citations
It is demonstrated that mitochondrial respiratory chain-related pathways, particularly those involving complexes III and IV, are consistently associated with the transcriptomic alterations observed in multiple sclerosis, providing evidence that mitochondrial bioenergetics and redox homeostasis may contribute to MS path...
Tatyana Tarkina, D. Azanbayeva, T. Algazina et al.· Naunyn-Schmiedeberg's Archiv...· 0 citations
This study provides a systems-level view of immune dysregulation in MG, highlighting enhanced intercellular communication, T-cell dysregulation, and PLEK as a potential molecular marker associated with CD8+ T-cell activation and disease severity, offering insights into MG pathogenesis and therapeutic targets.
Jing-Nan Jin, Zi-Hong Chen, Yi-Ying Zhang et al.· Journal of Neuroimmunology· 0 citations
A validated six-gene signature is proposed that refines prognostic stratification, delineates immunerelevant HCC subtypes and highlights candidate biomarkers for therapeutic selection and mechanistic investigation.
Yu-Xin Liang, Xing Chen, Yuhao Su et al.· Gene· 0 citations
An integrative single-cell eQTL-driven multi-omics framework to identify immune cell-specific causal genes and prioritize drug-repurposing candidates for HNC supports AIM1 and ANXA1 as promising biomarkers and therapeutic entry points for precision drug development.
Zhangwei Xue, Guo-Hang Shen, Gongbiao Lin et al.· Frontiers in Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.